Adjunctive PCSK9 Inhibitor Evolocumab in the Prevention of Early Neurological Deterioration in Non-cardiogenic Acute Ischemic Stroke: A Multicenter, Prospective, Randomized, Open-Label, Clinical Trial.

已完结 10 由斯猫粒发布于 2025/4/8 20:44:48

DOI:10.1007/s40263-024-01145-5
作者：Wen Tian, Hua Cao, Xidan Li, Xing Gong, Xinting Yu, Dongyun Li, Jing Xie, Ying Bai, Dawei Zhang, Xiaohong Li, Ping Xu, Jiahui Liu, Bingwei Z
文献类型：期刊论文
补充材料：只需要正文

Springer

Abstract：Background: Early neurological deterioration (END) is associated with a poor prognosis in acute ischemic stroke (AIS). Effectively lowering low-density lipoprotein cholesterol (LDL-C) can im

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:American Chemical Society (ACS)Global Patterns and Drivers of Soil Dissimilatory Nitrate Reduction to Ammonium